Shanghai FDA to Present at ACI’s China Pharmaceutical Law Regulatory Boot Camp

NEW YORK - March 20, 2014 - PRLog -- American Conference Institute (ACI) is pleased to announce that Xiang Li, Officer, Division of Inspection at the Shanghai Food and Drug Administration (SFDA) will present at ACI’s China Pharmaceutical Law Regulatory Boot Camp which will take place in New York City on April 22, 2014.

In addition to the SFDA, this unique program features a distinguished faculty - including experts from Bayer, Pfizer, Sanofi, and Syncoda Technologies- who will address the challenges and opportunities facing the pharmaceutical industry in the burgeoning Chinese market including the intricacies of the drug and biologic approval process in China, obtaining meaningful intellectual property protection, Chinese cGMPs, and doing business in an atmosphere of heightened enforcement.

As Stephanie Butler, Division Manager of ACI’s  Life Sciences and Health Care  Division noted “ACI is proud and honored to work with this faculty, which is essentially a gathering of the ‘who’s who’ of the pharmaceutical regulatory bar doing business in China.  This conference presents a unique opportunity to not only hear from directly from the SFDA right here in New York, but to also hear from on-the-ground experts from the companies doing business in China who can share their real world knowledge on the challenges along the way to drug approval.”

Lisa J. Piccolo, Senior Industry Manager, Life Sciences and Health Care with ACI, stated “The time is ripe for a conference on China Pharmaceutical Regulatory law, as theemerging Chinese market is now the third largest globally, with many industry observers believing that it will soon eclipse Japan in the number two spot.  In light of the increased emphasis on the “global/multinational” nature of the pharmaceutical industry, attorneys and business executives in the U.S. also have a need to develop a working knowledge of Chinese pharmaceutical law and regulation.”

More information about this event, including a full agenda, faculty list, and brochure can be accessed at www.AmericanConference.com/ChinaPharma.

# # #

A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.

Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.

Headquartered in New York and led by  Leigh Gilmore, Senior Vice President, and Seth Kerker, Managing Director, American Conference Institute has grown to produce more than 220 events each year, attended by thousands of senior delegates from across the country.